{"transactions":[{"id":3605047,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-08T19:20:43.000Z","date":"2019-03-05","kind":"exercise","acquired":false,"shares":8421,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units vested on March 5, 2019, the accelerated vesting date.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units vested on March 5, 2019, the accelerated vesting date.  Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8421},"source":{"system":"sec-edgar","filing":"0001209191-19-018291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919119018291/doc4.xml","form_type":"4"}},{"id":3605046,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-08T19:20:43.000Z","date":"2019-03-05","kind":"exercise","acquired":true,"shares":8421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired upon vesting of restricted stock units awarded on May 21, 2018."}],"balance_after":102267,"source":{"system":"sec-edgar","filing":"0001209191-19-018291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919119018291/doc4.xml","form_type":"4"}},{"id":3921104,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-05-23T21:48:47.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":13352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on May 21, 2018. The award vests and becomes exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date."}],"balance_after":13352,"derivative":{"exercise_price":12.94,"expiration_date":"2028-05-21","underlying":"Common Stock","underlying_shares":13352},"source":{"system":"sec-edgar","filing":"0001209191-18-032799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919118032799/doc4.xml","form_type":"4"}},{"id":3921103,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-23T21:48:47.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":8421,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units awarded on May 21, 2018 vests on the first anniversary of the  grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units awarded on May 21, 2018 vests on the first anniversary of the  grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."}],"balance_after":8421,"derivative":{"underlying":"Common Stock","underlying_shares":8421},"source":{"system":"sec-edgar","filing":"0001209191-18-032799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919118032799/doc4.xml","form_type":"4"}},{"id":4187665,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-12T20:24:54.000Z","date":"2017-10-10","kind":"sale","acquired":false,"shares":100,"price":121.955,"value":12195.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":1870,"source":{"system":"sec-edgar","filing":"0001562180-17-003253","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003253/primarydocument.xml","form_type":"4"}},{"id":4212096,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-12T21:02:00.000Z","date":"2017-09-08","kind":"sale","acquired":false,"shares":100,"price":120.9383,"value":12093.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":1970,"source":{"system":"sec-edgar","filing":"0001562180-17-002935","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017002935/primarydocument.xml","form_type":"4"}},{"id":4235742,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-14T20:24:25.000Z","date":"2017-08-10","kind":"sale","acquired":false,"shares":100,"price":114.3,"value":11430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":2070,"source":{"system":"sec-edgar","filing":"0001562180-17-002667","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017002667/primarydocument.xml","form_type":"4"}},{"id":4244477,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-03T18:11:29.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":2250,"price":10.0742,"value":22666.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold.  The shares were sold in multiple trades at prices ranging from $9.95 to $10.17 per share, inclusive.  The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":93846,"source":{"system":"sec-edgar","filing":"0001209191-17-047492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919117047492/doc4.xml","form_type":"4"}},{"id":4258704,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-12T20:34:11.000Z","date":"2017-07-10","kind":"sale","acquired":false,"shares":100,"price":116.86,"value":11686.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":2170,"source":{"system":"sec-edgar","filing":"0001562180-17-002467","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017002467/primarydocument.xml","form_type":"4"}},{"id":4284520,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-13T20:56:10.000Z","date":"2017-06-09","kind":"sale","acquired":false,"shares":100,"price":113.62,"value":11362.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":2270,"source":{"system":"sec-edgar","filing":"0001562180-17-002258","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017002258/primarydocument.xml","form_type":"4"}},{"id":4298895,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T20:51:27.000Z","date":"2017-05-22","kind":"sale","acquired":false,"shares":1059,"price":110.014,"value":116504.826,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $110.00 to $110.05, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2370,"source":{"system":"sec-edgar","filing":"0001562180-17-002110","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017002110/primarydocument.xml","form_type":"4"}},{"id":4301902,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-30T19:18:45.000Z","date":"2017-05-26","kind":"exercise","acquired":false,"shares":20362,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CCXI common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the restricted stock units vested on May 26, 2017.  Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"100% of the restricted stock units vested on May 26, 2017.  Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20362},"source":{"system":"sec-edgar","filing":"0001209191-17-036280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919117036280/doc4.xml","form_type":"4"}},{"id":4301901,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T19:18:45.000Z","date":"2017-05-26","kind":"exercise","acquired":true,"shares":20362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were acquired upon vesting of restricted stock units awarded on May 26, 2016."}],"balance_after":96096,"source":{"system":"sec-edgar","filing":"0001209191-17-036280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919117036280/doc4.xml","form_type":"4"}},{"id":4301900,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T19:18:45.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":12912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock was awarded on May 25, 2017, and 100% of the restricted stock will vest on May 25, 2018, subject to the Reporting Person's continued service to the Company on such date.  Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date."}],"balance_after":75734,"source":{"system":"sec-edgar","filing":"0001209191-17-036280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919117036280/doc4.xml","form_type":"4"}},{"id":4323871,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-12T20:16:47.000Z","date":"2017-05-10","kind":"sale","acquired":false,"shares":100,"price":110.59,"value":11059.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":3429,"source":{"system":"sec-edgar","filing":"0001562180-17-001934","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017001934/primarydocument.xml","form_type":"4"}},{"id":4336062,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-03T19:06:35.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":4000,"price":7.3071,"value":29228.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold.  The shares were sold in multiple trades at prices ranging from $7.11 to $7.40 per share, inclusive.  The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":62822,"source":{"system":"sec-edgar","filing":"0001209191-17-029817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919117029817/doc4.xml","form_type":"4"}},{"id":4354069,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-12T20:52:23.000Z","date":"2017-04-10","kind":"sale","acquired":false,"shares":78,"price":101.13,"value":7888.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":3551,"source":{"system":"sec-edgar","filing":"0001562180-17-001502","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017001502/primarydocument.xml","form_type":"4"}},{"id":4354068,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-12T20:52:23.000Z","date":"2017-04-10","kind":"sale","acquired":false,"shares":22,"price":101.23,"value":2227.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":3529,"source":{"system":"sec-edgar","filing":"0001562180-17-001502","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017001502/primarydocument.xml","form_type":"4"}},{"id":4387440,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-14T20:43:07.000Z","date":"2017-03-10","kind":"sale","acquired":false,"shares":21,"price":107.81,"value":2264.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":3629,"source":{"system":"sec-edgar","filing":"0001562180-17-001257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017001257/primarydocument.xml","form_type":"4"}},{"id":4387439,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-14T20:43:07.000Z","date":"2017-03-10","kind":"sale","acquired":false,"shares":79,"price":107.76,"value":8513.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":3650,"source":{"system":"sec-edgar","filing":"0001562180-17-001257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017001257/primarydocument.xml","form_type":"4"}},{"id":4451549,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-14T22:03:56.000Z","date":"2017-02-10","kind":"sale","acquired":false,"shares":100,"price":102.6,"value":10260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":3729,"source":{"system":"sec-edgar","filing":"0001562180-17-000678","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017000678/primarydocument.xml","form_type":"4"}},{"id":4469774,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-03T17:42:54.000Z","date":"2017-02-01","kind":"sale","acquired":false,"shares":4000,"price":7.3226,"value":29290.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold.  The shares were sold in multiple trades at prices ranging from $7.26 to $7.41 per share, inclusive.  The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":66822,"source":{"system":"sec-edgar","filing":"0001209191-17-007763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919117007763/doc4.xml","form_type":"4"}},{"id":4492632,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-12T22:02:31.000Z","date":"2017-01-10","kind":"sale","acquired":false,"shares":100,"price":103.57,"value":10357.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":3829,"source":{"system":"sec-edgar","filing":"0001562180-17-000230","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017000230/primarydocument.xml","form_type":"4"}},{"id":4524630,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-13T21:31:32.000Z","date":"2016-12-09","kind":"sale","acquired":false,"shares":100,"price":108.9248,"value":10892.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016."}],"balance_after":3929,"source":{"system":"sec-edgar","filing":"0000914190-16-000956","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419016000956/edgar.xml","form_type":"4"}},{"id":4549496,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-18T21:33:51.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":100,"price":105.75,"value":10575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2016."}],"balance_after":4029,"source":{"system":"sec-edgar","filing":"0000914190-16-000872","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419016000872/edgar.xml","form_type":"4"}},{"id":4568626,"issuer":{"id":122928,"kind":"organization","name":"ChemoCentryx, Inc.","symbol":"CCXI"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T17:47:36.000Z","date":"2016-11-01","kind":"sale","acquired":false,"shares":4000,"price":6.1027,"value":24410.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of the shares sold.  The shares were sold in multiple trades at prices ranging from $5.84 to $6.18 per share, inclusive.  The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":70822,"source":{"system":"sec-edgar","filing":"0001209191-16-148239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/902080/000120919116148239/doc4.xml","form_type":"4"}},{"id":4572437,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-31T21:10:01.000Z","date":"2016-10-27","kind":"grant","acquired":true,"shares":3985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders."}],"balance_after":3985,"derivative":{"exercise_price":101.19,"expiration_date":"2026-10-26","underlying":"Common Stock","underlying_shares":3985},"source":{"system":"sec-edgar","filing":"0000914190-16-000864","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419016000864/edgar.xml","form_type":"4"}},{"id":4572436,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T21:10:01.000Z","date":"2016-10-27","kind":"grant","acquired":true,"shares":914,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4129,"source":{"system":"sec-edgar","filing":"0000914190-16-000864","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419016000864/edgar.xml","form_type":"4"}},{"id":4572435,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T21:10:01.000Z","date":"2016-10-19","kind":"sale","acquired":false,"shares":100,"price":104.71,"value":10471.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2016."}],"balance_after":3215,"source":{"system":"sec-edgar","filing":"0000914190-16-000864","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419016000864/edgar.xml","form_type":"4"}},{"id":4596687,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":159321,"kind":"person","name":"LUCAS ROGER C","position":1,"cik":"0000902080","reported_name":"LUCAS ROGER C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-23T20:40:33.000Z","date":"2016-09-21","kind":"sale","acquired":false,"shares":100,"price":108.91,"value":10891.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2016."}],"balance_after":3315,"source":{"system":"sec-edgar","filing":"0000914190-16-000839","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419016000839/edgar.xml","form_type":"4"}}]}